US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ブラジル
BOV
Sao Carlos Empreendimentos Participacoes Sa (SCAR3) 銘柄情報

Sao Carlos Empreendimentos Participacoes Sa (SCAR3)

12.27

0.13

(1.07%)

終了 6月13日 5:55AM

Sao Carlos Empreendimentos Participacoes Sa (SCAR3) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

12.27

( 1.07% )

買値

12.02

売値

12.89

出来高

3,900

12.26 日の範囲 12.59

12.05 52 週間の範囲 29.00

時価総額

前日終値

12.14

始値

12.50

時刻

最終取引時間

財務取引量

R$ 48,052

VWAP

12.321

平均取引量 (3 か月)

R$ 41,517

発行済株式数

57,201,905

配当利回り

7.1

PER

-9.39

1 株当たり利益 (EPS)

-1.47

歳入

284.41M

純利益

-83.91M

São Carlos Empreendimentos e Participações S.A. operates as a real estate investment and management company in Brazil. The company is involved in management of own or third-party real estate developments, including shopping malls centers; purchase and sale of ready-made or under-construction residen... São Carlos Empreendimentos e Participações S.A. operates as a real estate investment and management company in Brazil. The company is involved in management of own or third-party real estate developments, including shopping malls centers; purchase and sale of ready-made or under-construction residential and commercial properties; leasing of real estate; and operation of rotating parking. Its portfolio includes office buildings and convenience centers. São Carlos Empreendimentos e Participações S.A. was incorporated in 1989 and is based in São Paulo, Brazil. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.scsa.com.br

本社

São Paulo, Brazil

設立

1989

Sao Carlos Empreendimentos Participacoes Sa is listed in the sector of the ボベスパ (ブラジル) with ticker SCAR3. The last closing price for SÃO CARLOS ON was R$12.14. Over the last year, SÃO CARLOS ON shares have traded in a share price range of R$ 12.05 to R$ 29.00.

SÃO CARLOS ON currently has 57,201,905 shares in issue. The market capitalisation of SÃO CARLOS ON is R$701.87 million. SÃO CARLOS ON has a price to earnings ratio (PE ratio) of -9.39.

Sao Carlos reports net income of R$ 221 million and revenue from leases increase of 21% in 2012

Sao Carlos reports net income of R$ 221 million and revenue from leases increase of 21% in 2012 Company closes the year with a portfolio value of...

Sao Carlos Reports EBITDA growth of 26% in 3Q12: Portfolio increases 28% in 12 months and NAV reaches R$52/share

Sao Carlos Reports EBITDA growth of 26% in 3Q12: Portfolio increases 28% in 12 months and NAV reaches R$52/share /* Style Definitions */...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.58	-4.51361867704	12.85	13.49	12.05	23060	12.28193408	CS
4	-1.57	-11.3439306358	13.84	14.01	12.05	28842	13.13868613	CS
12	-1.56	-11.2798264642	13.83	15.54	12.05	44545	14.33502385	CS
26	-1.71	-12.2317596567	13.98	15.69	12.05	51520	14.22252992	CS
52	-4.45	-26.6148325359	16.72	29	12.05	75469	19.02826632	CS
156	-7.65	-38.4036144578	19.92	29	12.05	40205	19.53626794	CS
260	-29.4	-70.5543556515	41.67	43.35	11.82	27707	20.12047344	CS

SCAR3 - Frequently Asked Questions (FAQ)

What is the current Sao Carlos Empreendimentos Participacoes Sa share price?

The current share price of Sao Carlos Empreendimentos Participacoes Sa is R$ 12.27

How many Sao Carlos Empreendimentos Participacoes Sa shares are in issue?

Sao Carlos Empreendimentos Participacoes Sa has 57,201,905 shares in issue

What is the market cap of Sao Carlos Empreendimentos Participacoes Sa?

The market capitalisation of Sao Carlos Empreendimentos Participacoes Sa is BRL 701.87M

What is the 1 year trading range for Sao Carlos Empreendimentos Participacoes Sa share price?

Sao Carlos Empreendimentos Participacoes Sa has traded in the range of R$ 12.05 to R$ 29.00 during the past year

What is the PE ratio of Sao Carlos Empreendimentos Participacoes Sa?

The price to earnings ratio of Sao Carlos Empreendimentos Participacoes Sa is -9.39

What is the cash to sales ratio of Sao Carlos Empreendimentos Participacoes Sa?

The cash to sales ratio of Sao Carlos Empreendimentos Participacoes Sa is 2.77

What is the registered address of Sao Carlos Empreendimentos Participacoes Sa?

The registered address for Sao Carlos Empreendimentos Participacoes Sa is Rua Dr. Eduardo de Souza Aranha, São Paulo, São Paulo, 04543-904

What is the Sao Carlos Empreendimentos Participacoes Sa website address?

The website address for Sao Carlos Empreendimentos Participacoes Sa is www.scsa.com.br

Whalatane

Whalatane 7分前

My debate with Claude
Velphoro leaves 100% TDAPA reimbursement Dec 31st 2026 . OLC if approved starts 100% reimbursement ...so won't Fresenius want to switch patients to OLC especially if licensed by CSL Vifor9:44 PM

????Claude responded:
That changes the calculus mean

shajandr

shajandr 8分前

I bought this one in 2025 and am pleased with it so far.

https://investorshub.advfn.com/uimage/uploads/2026/6/13/xfifamueller.JPG

https://www.amazon.com/dp/B0DRDNZDHK?ref=ppx_yo2ov_dt_b_fed_asin_title&th=1

BTW, when I put the bunnies' food ~OUTT under the

jour_trader

jour_trader 10分前

lol there was no waiver. Glad you are now caught up on the real timeline.

wadegarret

wadegarret 14分前

Valuemind- SNDK

Are you not concerned that despite only a 11-12 PE going forward, that this is a highly cyclical stock up from $30 a year ago ? I mean in other words, if judging the value of a stock today is based on future earnings going out at least 2-3 years, how can one have

Whalatane

Whalatane 17分前

Searched the webHere's the mechanism if OLC (Renazorb) gets FDA approval and TDAPA designation:...via Claude

Normal economics without TDAPA:
Phosphate binders fall inside Medicare's ESRD bundled payment (~$281.71/treatment). Any drug a clinic uses comes out of that fixed bund

mmayr

Complete Meltdown is Coming

https://youtu.be/5sp1minxEns?is=-W1we0evirBu6yX9

boston127

boston127 24分前

Something good is happening here.

I'm not dumping, just trying to sell high and buy low.

shajandr

shajandr 25分前

As you've nott replied to my questions (perhaps you, like many/most others have me on Ignore), infra, prolly in view of there being no meritorious argument supporting the SEC's so-kalt 'gag rule' on settlements, I've restructured my inquiry. I'd still enjoy reading your reply to the original questio

janice shell

janice shell 25分前

I'll bet you can even get ivermectin at Amazon now. You can get everything at Amazon.

Damn, should I get this? It's tempting. Fantastic price:

https://investorshub.advfn.com/uimage/uploads/2026/6/13/vujmmimage.jpeg

https://www.amazon.com/EDGING-CASTING-En

bim524

bim524 26分前

Maybe you should go to an Amazon board and complain over there Instead of spreading this nonsense about a fake agreement here. If you even had any semblance of historical fact you would pretend to know that this company won’t even name companies in their PRs… if they issue a statement that says ther

Just give me $1.50

Just give me $1.50 26分前

Huh?

You haven't been watching and/or listening to the news?

Because of peace talks failing, and the War in Iran restarting, Elite submitted a waiver request to the SEC to have their 10-K filing deadline pushed back by two weeks due to safety concerns.

It

HyGro

No biotech passes on the chance for an FDA approval -- NWBO sure did and likely because FDA told them not to bother. No oncology drug can be very profitable with out U.S. approval. NWBO didn't even try. Why, because they knew they wouldn't get accepted. Just watch, NWBO won't apply for FDA

grantastic

grantastic 29分前

It is crazy to believe that HDUP is pursuing any legitimate business deals.

Especially after Mark Hutchison scrubbed all mention of HDUP from his professional profile. He's moved on from the scam. Shareholders need to move on too.

The only evidence ever shown of these

sandor8

sandor8 29分前

It is only proving to itself to be part of the group of psychopath an sociopath world over known today, only needing a driver of a tank to hint physically to them that our essence can be flattened, quite simplifying and ameliorating the other's existence.

normal investor

normal investor 33分前

Just give me $1.50

Just give me $1.50 33分前

LMAO.

1-2 years?

You mean 1-2 ............. WEEKS?

Shareholder: "Is the timeline for uplisting to NASDAQ or acquisition merger still on track to be around August 2026?"

Nasrat: "NO!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"

nowwhat2

nowwhat2 38分前

https://investorshub.advfn.com/uimage/uploads/2026/6/13/kgwzibtc_june_12_zoom_cup_depend.jpghttps://investorshub.advfn.com/uimage/uploads/2026/6/13/wvapvdepend_sikh.jpg

.

mrwrn2010

mrwrn2010 40分前

What I’m reading seems to indicate that Elite is still not prevented from obtaining *tentative approval* from the FDA on the OxyContin ANDA, only that they can’t get final approval until/after 8/24/27. I believe Nasrat also confirmed this last call. Ideally, we see a tentative Oxy approval sometime

Just give me $1.50

Just give me $1.50 43分前

***** I just paid for the new documents *****

Friday, June 12, 2026

STIPULATION AND ORDER REGARDING IRREVOCABLE COVENANT NOT TO COME TO MARKET AND DISMISSAL. Signed by Judge Karen M. Williams on 6/12/2026.

3331

The premise is clear: the most lucrative investments are the ones made before the rest of the world catches on. IT'S NO SECRET, THE KEY IS TO GET IN EARLY!

The SpaceX IPO created 4,400 millionaires in minutes, and over 400 people made over $100 Million, despite never turning a pr

WATERFALL1

WATERFALL1 46分前

Agreed

We are facing reversal to North direction

Patience is needed

WATERFALL1

WATERFALL1 47分前

Do you want to kidding us with your opinion ?

grantastic

grantastic 49分前

I'm not here to "help" scammers that make bogus claims.

In hindsight, most of my APRU takes were proven accurate. Were they "helpful" to anyone? I can hope so, but I have no idea if I actually saved anyone from the idiotic mistake of thinking APRU was a legitimate enterprise.

BriaCell Therapeutics

Leverage Shares 5x Short...

0.375% coupon until 04.2...

Invesco Markets II

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。